- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic approaches to diabetic nephropathy—beyond the RAS
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 10, Issue 6, Pages 325-346
Publisher
Springer Nature
Online
2014-05-06
DOI
10.1038/nrneph.2014.74
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A1.72 Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study1
- (2014) Peter Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
- (2014) Aaron H Burstein et al. BMC Neurology
- The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study
- (2014) Tatsuo Hosoya et al. Trials
- US Renal Data System 2013 Annual Data Report
- (2013) Allan J. Collins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renal Antifibrotic Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in Diabetic Rats
- (2013) G. Castoldi et al. AMERICAN JOURNAL OF NEPHROLOGY
- Human Mesenchymal Precursor Cells (Stro-1+) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
- (2013) Stuart I. Hodgetts et al. CELL TRANSPLANTATION
- Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac Function
- (2013) Jaco H. Houtgraaf et al. CIRCULATION RESEARCH
- Short-Term Changes after a Weight Reduction Intervention in Advanced Diabetic Nephropathy
- (2013) A. N. Friedman et al. Clinical Journal of the American Society of Nephrology
- Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study
- (2013) David M. Maahs et al. Current Diabetes Reports
- Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression
- (2013) Dingkun Gui et al. CYTOKINE
- Inhibition of Src Kinase Blocks High Glucose-Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice
- (2013) K. Taniguchi et al. DIABETES
- Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
- (2013) P.-H. Groop et al. DIABETES CARE
- Factors Associated With Microalbuminuria in 7,549 Children and Adolescents With Type 1 Diabetes in the T1D Exchange Clinic Registry
- (2013) Mark Daniels et al. DIABETES CARE
- Kidney Disease and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2013) Ian H. de Boer et al. DIABETES CARE
- Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
- (2013) E. I. Ekinci et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Diabetes and gout: efficacy and safety of febuxostat and allopurinol
- (2013) M. A. Becker et al. DIABETES OBESITY & METABOLISM
- DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1^|^alpha; in type 2 diabetic patients with incipient nephropathy
- (2013) Hiroki Fujita et al. ENDOCRINE JOURNAL
- Hemin Therapy Improves Kidney Function in Male Streptozotocin-Induced Diabetic Rats: Role of the Heme Oxygenase/Atrial Natriuretic Peptide/Adiponectin Axis
- (2013) Joseph Fomusi Ndisang et al. ENDOCRINOLOGY
- Probucol Suppresses Initiation of Chronic Hemodialysis Therapy and Renal Dysfunction-Related Death in Diabetic Nephropathy Patients: Sakura Study
- (2013) Kei Endo et al. Journal of Atherosclerosis and Thrombosis
- CD73-Dependent Generation of Adenosine and Endothelial Adora2b Signaling Attenuate Diabetic Nephropathy
- (2013) E. Tak et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
- (2013) M. Afkarian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
- (2013) Vlado Perkovic et al. KIDNEY INTERNATIONAL
- Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?
- (2013) Toshio Miyata et al. KIDNEY INTERNATIONAL
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
- (2013) Miao Lin et al. KIDNEY INTERNATIONAL
- The GFR and GFR decline cannot be accurately estimated in type 2 diabetics
- (2013) Flavio Gaspari et al. KIDNEY INTERNATIONAL
- Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy
- (2013) Xi Xie et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
- (2013) Marcel H. A. Muskiet et al. Nature Reviews Nephrology
- The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation
- (2013) K. J. Neff et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Nrf2 pathway in the progression of renal disease
- (2013) C. Zoja et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Therapies for Diabetic Kidney Disease
- (2013) Jonathan Himmelfarb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Celastrol, an NF-κB Inhibitor, Improves Insulin Resistance and Attenuates Renal Injury in db/db Mice
- (2013) Jung Eun Kim et al. PLoS One
- Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury
- (2013) Li Fang et al. PLoS One
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Effects of Oral Paricalcitol on Secondary Hyperparathyroidism and Proteinuria of Kidney Transplant Patients
- (2013) Esther Gonzalez et al. TRANSPLANTATION
- Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients
- (2013) Makoto Ayaori et al. Journal of the American Heart Association
- Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1
- (2013) J. A. Tumlin et al. Journal of Diabetes Research
- Notice
- (2013) Kidney International Supplements
- Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Mohammad Kazem Fallahzadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
- (2012) AMERICAN JOURNAL OF KIDNEY DISEASES
- Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice
- (2012) Caylib A. Durand et al. AUTOIMMUNITY
- Bindarit
- (2012) Eugenio Mora et al. CELL CYCLE
- A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
- (2012) D. S. Hong et al. CLINICAL CANCER RESEARCH
- Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
- (2012) Mona Sedeek et al. CLINICAL SCIENCE
- AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation
- (2012) R. Fernandez-Sanchez et al. CURRENT MEDICINAL CHEMISTRY
- Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus
- (2012) G. Schernthaner et al. DIABETES OBESITY & METABOLISM
- Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy
- (2012) S. Kimura et al. DIABETES OBESITY & METABOLISM
- Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
- (2012) D. E. Bonds et al. DIABETOLOGIA
- Evaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetes
- (2012) So Young Park et al. ENDOCRINE JOURNAL
- Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice
- (2012) D. H. Nam et al. ENDOCRINOLOGY
- Implementation of proteomic biomarkers: making it work
- (2012) Harald Mischak et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats
- (2012) Sang-Hoon Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Targeting chemokines in proteinuria-induced renal disease
- (2012) Juan Antonio Moreno et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Fc Receptor Deficiency Attenuates Diabetic Nephropathy
- (2012) V. Lopez-Parra et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy
- (2012) S. Putta et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Exogenous activated protein C inhibits the progression of diabetic nephropathy
- (2012) P. GIL-BERNABE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
- (2012) Markus L. Alter et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Adenosine A2B receptor-mediated VEGF induction promotes diabetic glomerulopathy
- (2012) Angel Cárdenas et al. LABORATORY INVESTIGATION
- Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)
- (2012) Dennis L. Andress et al. LIFE SCIENCES
- Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?
- (2012) Donald E. Kohan et al. LIFE SCIENCES
- Nonproteinuric Diabetic Nephropathy
- (2012) Jamie P. Dwyer et al. MEDICAL CLINICS OF NORTH AMERICA
- Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
- (2012) Hikaru Sugimoto et al. NATURE MEDICINE
- Proteinuria as a surrogate end point—more data are needed
- (2012) Aliza Thompson Nature Reviews Nephrology
- Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases
- (2012) E. Morales et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Vitamin D receptor activation and cardiovascular disease
- (2012) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
- (2012) F. Bock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- d-Saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling
- (2012) Semantee Bhattacharya et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes
- (2012) Ravichandran Ramasamy et al. VASCULAR PHARMACOLOGY
- Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?
- (2012) Beatriz Fernandez-Fernandez et al. BMC Nephrology
- Notice
- (2012) Kidney International Supplements
- Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
- (2011) Edmund J. Lewis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Aldosterone-Induced Fibrosis in the Kidney: Questions and Controversies
- (2011) Andrew S. Brem et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Evaluation of JNK Blockade as an Early Intervention Treatment for Type 1 Diabetic Nephropathy in Hypertensive Rats
- (2011) Andy K.H. Lim et al. AMERICAN JOURNAL OF NEPHROLOGY
- Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis
- (2011) Alessandro Ble et al. AMERICAN JOURNAL OF NEPHROLOGY
- Dual Blockade of the Homeostatic Chemokine CXCL12 and the Proinflammatory Chemokine CCL2 Has Additive Protective Effects on Diabetic Kidney Disease
- (2011) Murthy N. Darisipudi et al. AMERICAN JOURNAL OF PATHOLOGY
- Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and MicroalbuminuriaAn Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications CohortMicroalbuminuria Outcomes in Type 1 Diabetes
- (2011) Ian H. de Boer ARCHIVES OF INTERNAL MEDICINE
- Oral Administration of Ethyl Acetate-Soluble Portion of Terminalia chebula Conferring Protection from Streptozotocin-Induced Diabetic Mellitus and Its Complications
- (2011) Ji-hoon Kim et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
- (2011) M. Kitada et al. DIABETES
- Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
- (2011) F. Barutta et al. DIABETES
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
- (2011) Kathrin Eller et al. DIABETES
- Does Therapy With Anti-TNF- Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?
- (2011) M. Gupta-Ganguli et al. DIABETES CARE
- Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study
- (2011) R.-D. Ting et al. DIABETES CARE
- Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice
- (2011) S. M. Ka et al. DIABETOLOGIA
- Autophagy as a Therapeutic Target in Diabetic Nephropathy
- (2011) Yuki Tanaka et al. Experimental Diabetes Research
- Incretin-based therapies - review of the physiology, pharmacology and emerging clinical experience
- (2011) J. H. Martin et al. INTERNAL MEDICINE JOURNAL
- Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy
- (2011) Masanori Abe et al. Journal of Atherosclerosis and Thrombosis
- MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Itsin VivoKnockdown Prevents Progression of Diabetic Nephropathy
- (2011) Jianyin Long et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
- (2011) D. E. Kohan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pyridorin in Type 2 Diabetic Nephropathy
- (2011) E. J. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
- (2011) D. K. Packham et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pirfenidone for Diabetic Nephropathy
- (2011) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
- (2011) Sufyan G. Sayyed et al. KIDNEY INTERNATIONAL
- Paricalcitol for reduction of albuminuria in diabetes
- (2011) Alberto Ortiz et al. LANCET
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Stopping Renin-Angiotensin System Inhibitors in Chronic Kidney Disease: Predictors of Response
- (2011) Anderson Roman Gonçalves et al. NEPHRON CLINICAL PRACTICE
- Can ACE Inhibitors and Angiotensin Receptor Blockers Be Detrimental in CKD Patients
- (2011) Macaulay A.C. Onuigbo NEPHRON CLINICAL PRACTICE
- Transfused Macrophages Ameliorate Pancreatic and Renal Injury in Murine Diabetes Mellitus
- (2011) Dong Zheng et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Reengineering Translational Science: The Time Is Right
- (2011) F. S. Collins Science Translational Medicine
- Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice
- (2011) Ahmed A. Elmarakby et al. VASCULAR PHARMACOLOGY
- Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study
- (2011) Jamie P. Dwyer et al. CardioRenal Medicine
- Effects of Combination Lipid Therapy in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
- (2010) Andrew M. Tonkin et al. CIRCULATION
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
- (2010) T. Jiang et al. DIABETES
- A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
- (2010) A. Alkhalaf et al. DIABETES CARE
- Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
- (2010) M. E. Molitch et al. DIABETES CARE
- High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up
- (2010) L. H. Ficociello et al. DIABETES CARE
- DPP-4 inhibitors: What may be the clinical differentiators?
- (2010) John Gerich DIABETES RESEARCH AND CLINICAL PRACTICE
- Pentoxifylline for Renoprotection in Diabetic Nephropathy: the PREDIAN study. Rationale and basal results
- (2010) Juan F. Navarro-González et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- BASP1 Promotes Apoptosis in Diabetic Nephropathy
- (2010) M. D. Sanchez-Nino et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- NF- B in Renal Inflammation
- (2010) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
- (2010) G. Ortiz-Munoz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- The expanding spectrum of biological actions of vitamin D
- (2010) J. Rojas-Rivera et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of role of doxycycline (a matrix metalloproteinase inhibitor) on renal functions in patients of diabetic nephropathy
- (2010) Hari Krishan Aggarwal et al. RENAL FAILURE
- Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial
- (2009) Steven Fishbane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
- (2009) R. R. Wenzel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: The DEMAND Study
- (2009) M.C.E. Rossi et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits
- (2008) Katarzyna Winiarska et al. BIOCHIMIE
- High-Normal Serum Uric Acid Is Associated with Impaired Glomerular Filtration Rate in Nonproteinuric Patients with Type 1 Diabetes
- (2008) E. T. Rosolowsky et al. Clinical Journal of the American Society of Nephrology
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- (2008) C. C. Berthier et al. DIABETES
- Different roles for TGF-β and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy
- (2008) Fuad N. Ziyadeh DIABETES RESEARCH AND CLINICAL PRACTICE
- Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications
- (2008) S Budhiraja et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease
- (2008) Pooneh Alborzi et al. HYPERTENSION
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
- (2008) P. P. Wolkow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes
- (2008) Adeel Ijaz et al. KIDNEY INTERNATIONAL
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Paget's Disease of the Mandible
- (2008) Mayank B. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
- (2007) M. Petersen et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More